New Techniques Developed to Make Breast Enlargement Safer: New Hampshire Plastic Surgeon Dr. Peter Pacik Reduces Common Complications With Combination of Three Innovative Techniques
Publication Date: 6/12/2006

Abstract: Manchester, NH June 12, 2006 – Dr. Peter T. Pacik, founder of the Plastic Surgery Center, presented a combination of three techniques developed over the past 4 ½ years to make breast enlargement surgery safer and more effective at the 47th annual meeting of the New England Society of Plastic and Reconstructive Surgeons, Inc. in New Castle, New Hampshire (June 2nd through June 4th, 2006).

Dr. Peter Pacik Performs Augmentation Mammaplasty Study With Excellent Aesthetic Results
Publication Date: 9/23/2005

Abstract: New Technique Improves Breast Rounding and Fullness and Prevents Breast Fold Lowering

Read more about the Dr. Pacik's advances in augmentation mammaplasty.

Mentor Receives Approvable Notification From FDA for Its Silicone Gel-Filled Breast Implants
Publication Date: 7/28/2005

Abstract: SANTA BARBARA, Calif.--(BUSINESS WIRE)--July 28, 2005--Mentor Corporation (NYSE:MNT), a leading supplier of medical products in the United States and internationally, today announced that it has received an "approvable letter" from the U.S. Food and Drug Administration (FDA) for the Company's MemoryGel(TM) silicone gel-filled breast implants. The approvable letter stipulates a number of conditions which Mentor must satisfy in order to receive FDA approval to market and sell silicone gel-filled breast implants in the United States.

Mentor Launches Moderate Plus Profile Saline-Filled Breast Implant Product Line in the U.S.
Publication Date: 9/7/2005

Abstract: SANTA BARBARA, Calif.--(BUSINESS WIRE)--Sept. 7, 2005--Mentor Corporation (NYSE:MNT), a leading supplier of medical products in the United States and internationally, today announced that it had launched its new Moderate Plus Profile saline-filled breast implant product line in the United States. The Moderate Plus Profile saline-filled breast implant product line was approved by the U.S. Food and Drug Administration (FDA) for use in breast augmentation and breast reconstruction surgeries.